Source:http://linkedlifedata.com/resource/pubmed/id/10206757
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1999-4-15
|
pubmed:abstractText |
We evaluated the in vitro activity of fluconazole, itraconazole, ketoconazole, 5-fluorocytosine and amphotericin B against 30 clinical isolates of Saccharomyces cerevisiae by a broth microdilution method, following the NCCLS recommendation. Testing was performed either in RPMI-1640 or yeast nitrogen base (YNB). YNB supported the growth of all isolates tested, while results in RPMI-1640 were not obtained for six isolates (20%). The MIC of all three azoles in YNB were one or two dilutions higher than those obtained in RPMI-1640 (P=0.0001 for fluconazole and itraconazole, P=0.03 for ketoconazole). Elevated MICs were observed for all three azoles, while all the isolates were susceptible to 5-fluorocytosine and amphotericin B. All MIC values were confirmed by spectrophotometric reading. Six strains of S. cerevisiae isolated from the faeces and consecutive blood cultures from an AIDS patient over a 7-month period were typed by electrophoretic karyotyping (EK). EK showed the maintenance of the same karyotype over time suggesting that the faecal isolate changed from a colonizing to infection-causing strain. The relative resistance of S. cerevisiae to azole drugs as well as its ability to cause widespread infections may promote the emergence of this species as a pathogen in immunosuppressed patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1369-3786
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
437-40
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:10206757-AIDS-Related Opportunistic Infections,
pubmed-meshheading:10206757-Amphotericin B,
pubmed-meshheading:10206757-Antifungal Agents,
pubmed-meshheading:10206757-Azoles,
pubmed-meshheading:10206757-Blood,
pubmed-meshheading:10206757-Electrophoresis, Agar Gel,
pubmed-meshheading:10206757-Feces,
pubmed-meshheading:10206757-Humans,
pubmed-meshheading:10206757-Karyotyping,
pubmed-meshheading:10206757-Microbial Sensitivity Tests,
pubmed-meshheading:10206757-Mycoses,
pubmed-meshheading:10206757-Saccharomyces cerevisiae
|
pubmed:year |
1998
|
pubmed:articleTitle |
In vitro activity of five antifungal agents against clinical isolates of Saccharomyces cerevisiae.
|
pubmed:affiliation |
Institute of Infectious Diseases and Public Health of the University of Ancona, Italy. cmalinf@popcsi.unian.it
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|